News FAMHP

There are 1 result(s) found based on your search criteria

1-1 from 1 result(s)

Flash VIG-news : MANIPREX® (lithium carbonate): temporary halt to marketing that may be problematic for the treatment of certain patients

The company Kela Pharma has indicated that, due to production issues, its Maniprex® 250 mg coated tablets and Maniprex® 500 mg film-coated tablets will be unavailable for an indefinite period once current stocks have been exhausted. The stock of Maniprex® 500 mg has already been exhausted, and Kela Pharma predicts, based on normal circumstances, that the stock of Maniprex® 250 mg will be exhausted by June 2018.

1-1 from 1 result(s)